Nemes Rush Group
EBS icon

Nemes Rush Group’s Emergent Biosolutions EBS Stock Holding History

Nemes Rush Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.62K Buy
+700
New +$4.6K ﹤0.01% 665
2024
Q4 		– Sell
-42
Closed -$106 – 749
2024
Q3 		$106 Hold
42
– – ﹤0.01% 597
2024
Q2 		$286 Hold
42
– – ﹤0.01% 586
2024
Q1 		$107 Hold
42
– – ﹤0.01% 656
2023
Q4 		$101 Hold
42
– – ﹤0.01% 649
2023
Q3 		$143 Hold
42
– – ﹤0.01% 634
2023
Q2 		$309 Buy
+42
New +$389 ﹤0.01% 658

Other funds holding EBS

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Values First Advisors
Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Nemes Rush Group's EBS Position: Q3 2026 in Review

Nemes Rush Group opened a new position in Emergent Biosolutions (EBS) in Q3 2026: 700 shares worth $4.62K. The stake represents ﹤0.01% of the portfolio and ranks #665 among its holdings. This is a return to the name: Nemes Rush Group previously reported a position in EBS as recently as Q3 2024.

Nemes Rush Group first reported a position in EBS in Q2 2023 and has held it in 7 quarters since. 78 funds tracked by Wall St. Rank hold EBS as of Q3 2026.

  • Nemes Rush Group held 700 shares of Emergent Biosolutions worth $4.62K as of Q3 2026.
  • Emergent Biosolutions was a new Nemes Rush Group position in Q3 2026.
  • Emergent Biosolutions made up ﹤0.01% of Nemes Rush Group's portfolio in Q3 2026, its #665 holding.
  • Nemes Rush Group first reported a position in Emergent Biosolutions in Q2 2023 and has held it in 7 quarters since.
  • 78 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2026.

Based on Nemes Rush Group's 13F filing for Q3 2026, filed 4 Nov 2026.